Shasha Wang

机构：Qingdao University, Chinese Academy of Medical Sciences & Peking Union Medical College, Affiliated Hospital of Qingdao University, First People's Hospital of Chongqing · ORCID：0000-0001-6262-0537

发表论文 45 篇 · 总被引 485 次 · h-index 13

代表论文

• PKM2-mediated metabolic reprogramming of microglia in neuroinflammation (2025 · Cell Death Discovery · 被引 33)
• Tunneling nanotubes: The transport highway for astrocyte-neuron communication in the central nervous system (2024 · Brain Research Bulletin · 被引 31)
• A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials (2022 · Haematologica · 被引 20)
• Trends of Phase I Clinical Trials of New Drugs in Mainland China Over the Past 10 Years (2011–2020) (2021 · Frontiers in Medicine · 被引 20)
• Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC (2022 · Journal of Translational Medicine · 被引 18)
• Rg1 exerts protective effect in CPZ-induced demyelination mouse model via inhibiting CXCL10-mediated glial response (2021 · Acta Pharmacologica Sinica · 被引 14)